External organizationAbbVie Deutschland GmbH & Co. KG

Basic data

Name:

AbbVie Deutschland GmbH & Co. KG

Country:

Germany

Region/province:

Hessen

City:

Wiesbaden

URL:

https://www.abbvie.de/

Projects

Klinische Studie

2017 - 2021

AbbVie Deutschland GmbH & Co. KG

M23-696 – A Phase 3b/4 Randomized, Open-label, Efficacy Assessor Blinded Study, Comparing theSafety and Assessor Blinded Efficacy of Upadacitinib to Dupilumab in Subjects with Moderate to SevereAtopic Dermatitis (Level-Up)

2023 - 2025

AbbVie Deutschland GmbH & Co. KG

Help

will be deleted permanently. This cannot be undone.